US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

148.73

-1.2850-0.86%

Volume:220.81K

Turnover:33.28M

Market Cap:479.56M

PE:- -

High:154.44

Open:148.66

Low:147.62

Close:150.01

52wk High:198.18

52wk Low:32.55

Shares:3.22M

Float Shares:3.22M

Volume Ratio:1.89

T/O Rate:6.85%

Dividend:1.34

Dividend Rate:0.90%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Zymeworks Announces Presentations for Ziihera(R) (zanidatamab-hrii) at 2026 AACR Annual Meeting

Analysts’ Top Healthcare Picks: X4 Pharmaceuticals (XFOR), Boston Scientific (BSX)

Maintaining Hold on Aldeyra as FDA CRL Clouds Reproxalap’s Dry Eye Path and Lowers Approval Odds

Hygeia Healthcare Schedules Board Meeting to Approve 2025 Annual Results

Waste Management Highlights CFO Transition And Stericycle Integration For Investors

Simply Wall St.

Analysts’ Top Healthcare Picks: GRAIL Inc (GRAL), Bicycle Therapeutics (BCYC)

Sanofi Says US FDA Grants Venglustat Breakthrough Therapy Designation for Type 3 Gaucher Disease

MT Newswires Live

MicroPort NeuroScientific Wins FDA Breakthrough Status for APOLLO Dream Neuro Stent

MICROPORT NEURO's APOLLO Dream® Sirolimus-Targeted Eluting Stent System Receives FDA Breakthrough Device Designation

Analysts’ Top Healthcare Picks: Orchestra BioMed Holdings (OBIO), Cardinal Health (CAH)

Target Healthcare REIT posts record half-year return as it recycles capital and strengthens balance sheet

Innodisk at NVIDIA GTC 2026: Accelerating Real-World AI for Healthcare and Mobility with Full-Stack Edge Solutions

Sunway Healthcare Shares Rise on Debut Despite Geopolitical Tensions

Thai Healthcare Sector Faces Headwinds From Middle East Conflict -- Market Talk

Icecure Medical Rides FDA, ASBRS Wins to Growth

Botanix Showcases FDA-Approved Hyperhidrosis Drug at Euroz Hartleys Conference

Cross Country Healthcare CIO Departs, Assumes Advisory Role

Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX)

Analysts Offer Insights on Healthcare Companies: Canopy Growth (CGC) and Doximity (DOCS)

Lantheus announces three-month extension of LNTH-2501 PDUFA date

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LABU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":148.725,"timestamp":1774017583195,"preClose":150.01,"halted":0,"volume":220814,"delay":0,"changeRate":-0.008566095593627069,"floatShares":3224486,"shares":3224486,"eps":0,"marketStatus":"Trading","change":-1.285,"latestTime":"03-20 10:39:55 EDT","open":148.66,"high":154.44,"low":147.62,"amount":33282006.874379996,"amplitude":0.045464,"askPrice":149.75,"askSize":30,"bidPrice":149.38,"bidSize":30,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774036800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":150.01,"sharesOutstanding":3074486,"nav":145.807,"aum":470151875.04,"dividendRate":0.008977,"bidAskSpread":0.002107,"preHourTrading":{"tag":"盘前","latestPrice":149.08,"preClose":150.01,"latestTime":"09:29 EDT","volume":2670,"amount":395890.9659,"timestamp":1774013390002,"change":-0.93,"changeRate":-0.0062,"amplitude":0.028865},"postHourTrading":{"tag":"盘后","latestPrice":150.8,"preClose":150.01,"latestTime":"19:59 EDT","volume":6614,"amount":993072.7812,"timestamp":1773964771547,"change":0.79,"changeRate":0.005266,"amplitude":0.008733},"volumeRatio":1.890582,"impliedVol":1.0212,"impliedVolPercentile":0.8287},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3224486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.890582,"shares":3224486,"dividePrice":1.3351,"high":154.44,"amplitude":0.045464,"preClose":150.01,"low":147.62,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":148.725,"eps":0,"divideRate":0.008977,"volume":220814,"delay":0,"ttmEps":0,"open":148.66,"prevYearClose":159.39,"prevWeekClose":148.85,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":148.85,"twentyDayClose":163.19,"sixtyDayClose":176.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620258691","title":"Press Release: Zymeworks Announces Presentations for Ziihera(R) (zanidatamab-hrii) at 2026 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258691","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620258691?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:46","pubTimestamp":1773834360,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, March 18, 2026  -- Zymeworks Inc. , a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that the company's partner, Jazz Pharmaceuticals, will present four abstracts featuring data from clinical trials evaluating Ziihera  at the American Association for Cancer Research  Annual Meeting, being held April 17-22, 2026 in San Diego, CA.\"We are pleased to see the continued clinical progress of zanidatamab reflected in multiple presentations at AACR,\" said Ken Galbraith, Chair, Chief Executive Officer, and Interim Chief Financial Officer of Zymeworks. \"These studies highlight emerging data evaluating zanidatamab across tumor types beyond biliary tract cancer and gastroesophageal adenocarcinoma, and contribute to the growing body of evidence supporting its potential across HER2-expressing cancers.\". -- An oral presentation with results from the Phas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4588","ZYME","BK4022","BK4555","BK4099","BTC","TM","R","BK4139","BK4232","LABU","PST","BK4585","03160","CDC"],"gpt_icon":0},{"id":"2620258086","title":"Analysts’ Top Healthcare Picks: X4 Pharmaceuticals (XFOR), Boston Scientific (BSX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620258086?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:40","pubTimestamp":1773834015,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on X4 Pharmaceuticals (XFOR – Research Report), Boston ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-x4-pharmaceuticals-xfor-boston-scientific-bsx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-x4-pharmaceuticals-xfor-boston-scientific-bsx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2087625088.SGD","XBI","SGXZ57979304.SGD","LU0267386448.USD","LU0353189763.USD","BSX","LU2265009873.SGD","LU0238689110.USD","LU1791710400.SGD","LU1061106388.HKD","SG9999001176.USD","IE0002141913.USD","BK4139","LU1153585028.USD","LU1989764748.USD","LU1791710582.SGD","LU0187121727.USD","LU1718418525.SGD","IE0009355771.USD","BK4137","LU1291159041.SGD","LU1720051108.HKD","LU0882574055.USD","LU0345769128.USD","LU0266013472.USD","LU0823417737.USD","LU2491050154.USD","XLV","LU0950375773.USD","HCSG","LU2506952097.USD","LU0345769631.USD","LU0048584097.USD","LU1057294990.SGD","LU1023059063.AUD","LU0823417653.USD","LU0823416689.USD","LU0128526141.USD","LU1366192091.USD","XFOR","LU1989764664.SGD","BK4504","LU1720051017.SGD","BK4581","LU2506952170.USD","LU2491049909.HKD","IE00BJJMRZ35.SGD","LABU","LU2362541273.HKD"],"gpt_icon":0},{"id":"2620234156","title":"Maintaining Hold on Aldeyra as FDA CRL Clouds Reproxalap’s Dry Eye Path and Lowers Approval Odds","url":"https://stock-news.laohu8.com/highlight/detail?id=2620234156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620234156?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:15","pubTimestamp":1773828932,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Matthew Caufield maintained a Hold rating on Aldeyra Therapeutics today and set a price target of $2.00. Matthew Caufield h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/maintaining-hold-on-aldeyra-as-fda-crl-clouds-reproxalaps-dry-eye-path-and-lowers-approval-odds-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/maintaining-hold-on-aldeyra-as-fda-crl-clouds-reproxalaps-dry-eye-path-and-lowers-approval-odds-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","IE00BFMHRM44.USD","LU0390134368.USD","BK4530","LABU","LU1815336091.USD","LU0757428866.USD","LU0128526141.USD","BK4121","BK4585","CRL"],"gpt_icon":0},{"id":"2620188234","title":"Hygeia Healthcare Schedules Board Meeting to Approve 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620188234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620188234?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:11","pubTimestamp":1773828689,"startTime":"0","endTime":"0","summary":"The latest update is out from Hygeia Healthcare Holdings Co., Ltd. ( ($HK:6078) ). Hygeia Healthcare Holdings Co., Limited has scheduled a board me...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-schedules-board-meeting-to-approve-2025-annual-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-schedules-board-meeting-to-approve-2025-annual-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","BK4588","HCSG","LABU","BK4581","LU0029874061.USD","XBI","XLV","BK4585"],"gpt_icon":0},{"id":"2620723701","title":"Waste Management Highlights CFO Transition And Stericycle Integration For Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2620723701","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620723701?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:03","pubTimestamp":1773828224,"startTime":"0","endTime":"0","summary":"Waste Management (NYSE:WM) has formally recognized outgoing CFO Devina Rankin for her leadership in integrating the Healthcare Solutions business following the Stericycle acquisition.\nThe acknowledgment also highlights her role in supporting the management transition as the company moves to a new CFO.\nThis recognition underscores the importance of the Stericycle deal and the new Healthcare Solutions segment in Waste Management's business mix.\n\nFor investors watching NYSE:WM, this leadership...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/190694-main-header/1756201957544","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/190694-main-header/1756201957544"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/commercial-services/nyse-wm/waste-management/news/waste-management-highlights-cfo-transition-and-stericycle-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/commercial-services/nyse-wm/waste-management/news/waste-management-highlights-cfo-transition-and-stericycle-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2028103732.USD","LU0289960550.SGD","LU2355687059.USD","LU1721428933.USD","LU0511384066.AUD","LU0472753341.HKD","SRCL","LU2271345857.HKD","LU0289961442.SGD","LU1430594728.SGD","LU1989772840.SGD","LU2089279066.USD","LU2362541513.USD","LU2298064838.USD","ISBC","LU1923622291.USD","LU2106854487.HKD","LU0069063385.USD","LU0158827781.USD","LU2092937221.SGD","LU2125909916.SGD","LU2023250843.SGD","LU2089283258.USD","LU2041044095.USD","LU2023250504.SGD","LU2413666426.HKD","LU2125910336.SGD","LU0175139822.USD","BK4588","LU0057025933.USD","LU0158827948.USD","BK4534","LU1989772923.USD","LU0289739343.SGD","BK4533","WM","LU1585245621.USD","LU1939255532.USD","LU0347712357.USD","XBI","LU2463526074.USD","BK4211","LU2238339852.HKD","LABU","LU1623119135.USD","LU1712237335.SGD","LU2413666699.HKD","BK4120","XLV","LU1974910355.USD"],"gpt_icon":0},{"id":"2620265231","title":"Analysts’ Top Healthcare Picks: GRAIL Inc (GRAL), Bicycle Therapeutics (BCYC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620265231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620265231?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:50","pubTimestamp":1773827405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GRAIL Inc (GRAL – Research Report) and Bicycle Thera...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-grail-inc-gral-bicycle-therapeutics-bcyc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-grail-inc-gral-bicycle-therapeutics-bcyc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","BK4139","BK4588","LU0128526141.USD","BK4137","GRAL","BCYC","XBI","XLV","LU0029874061.USD","LABU","HCSG"],"gpt_icon":0},{"id":"2620231361","title":"Sanofi Says US FDA Grants Venglustat Breakthrough Therapy Designation for Type 3 Gaucher Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2620231361","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620231361?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:47","pubTimestamp":1773827232,"startTime":"0","endTime":"0","summary":"Sanofi  said Wednesday the US Food and Drug Administration has granted breakthrough therapy designation for its investigational drug venglustat to treat  neurological manifestations of type 3 Gaucher disease.The company said the designation was based on results from a phase 3 study in which venglustat showed statistically significant improvements in neurological symptoms compared with enzyme replacement therapy imiglucerase.The treatment was generally well tolerated, with no new safety signals observed, Sanofi said.The company said it plans to pursue global regulatory filings for venglustat this year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNYNF","BK4588","SNY","BK4007","LABU","BK4585","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2620312372","title":"MicroPort NeuroScientific Wins FDA Breakthrough Status for APOLLO Dream Neuro Stent","url":"https://stock-news.laohu8.com/highlight/detail?id=2620312372","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620312372?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:42","pubTimestamp":1773826943,"startTime":"0","endTime":"0","summary":"The latest update is out from MicroPort NeuroTech Limited ( ($HK:2172) ). MicroPort NeuroScientific Corporation announced that its independently de...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/microport-neuroscientific-wins-fda-breakthrough-status-for-apollo-dream-neuro-stent?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/microport-neuroscientific-wins-fda-breakthrough-status-for-apollo-dream-neuro-stent?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"gpt_icon":0},{"id":"1103095135","title":"MICROPORT NEURO's APOLLO Dream® Sirolimus-Targeted Eluting Stent System Receives FDA Breakthrough Device Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1103095135","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103095135?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:24","pubTimestamp":1773825869,"startTime":"0","endTime":"0","summary":"MICROPORT NEURO (02172) announced that its independently developed APOLLO Dream® Sirolimus-Targeted Eluting Stent System (APOLLO Dream® Stent System) has recently been granted Breakthrough Device...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","BK4588","BK1100","02172","BK1222","BK1574","BK4585","159883","BK1583","09997","LABU"],"gpt_icon":0},{"id":"2620238026","title":"Analysts’ Top Healthcare Picks: Orchestra BioMed Holdings (OBIO), Cardinal Health (CAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620238026","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620238026?lang=en_us&edition=fundamental","pubTime":"2026-03-18 15:40","pubTimestamp":1773819622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Orchestra BioMed Holdings (OBIO – Research Report), ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-orchestra-biomed-holdings-obio-cardinal-health-cah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-orchestra-biomed-holdings-obio-cardinal-health-cah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0310800965.SGD","BK4082","LU0128525689.USD","LU0029874061.USD","LU0128526141.USD","LU0310799852.SGD","LU0211327993.USD","LU1571399168.USD","LU1267930813.SGD","BK4585","XLV","LU1880398554.USD","LU0889566641.SGD","LABU","SG9999001440.SGD","OBIO","BK4588","LU0154236417.USD","LU0211328371.USD","BK4581","XBI","HCSG","BK4137","LU1267930490.SGD","LU1267930227.SGD","LU0052756011.USD","LU0072461881.USD","LU1880398471.USD","BK4175","LU0792757196.USD","LU0006061336.USD","LU0162691827.USD","CAH"],"gpt_icon":0},{"id":"2620028090","title":"Target Healthcare REIT posts record half-year return as it recycles capital and strengthens balance sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2620028090","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620028090?lang=en_us&edition=fundamental","pubTime":"2026-03-18 15:17","pubTimestamp":1773818252,"startTime":"0","endTime":"0","summary":"Target Healthcare REIT ( ($GB:THRL) ) has shared an update. Target Healthcare REIT, a specialist investor in modern UK care homes, owns 86 properti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/target-healthcare-reit-posts-record-half-year-return-as-it-recycles-capital-and-strengthens-balance-sheet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/target-healthcare-reit-posts-record-half-year-return-as-it-recycles-capital-and-strengthens-balance-sheet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","LU0211327993.USD","LU1267930227.SGD","XLV","LU1244550221.USD","XBI","LU0128525689.USD","LU0211328371.USD","LU0029874061.USD","BK4596","BK4597","LU0823411888.USD","LU1244550577.SGD","LU2237443549.SGD","BK4137","BK4585","LU0052756011.USD","LU2237443978.SGD","LU0310800965.SGD","BK4504","LU0310799852.SGD","BK4155","LU1244550494.USD","BK4581","BK4532","LU2237443622.USD","HCSG","BK4533","LU1267930490.SGD","BK4114","LU2237443382.USD","TGT","LABU","REIT"],"gpt_icon":0},{"id":"2620837422","title":"Innodisk at NVIDIA GTC 2026: Accelerating Real-World AI for Healthcare and Mobility with Full-Stack Edge Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2620837422","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620837422?lang=en_us&edition=fundamental","pubTime":"2026-03-18 10:52","pubTimestamp":1773802320,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., March 18, 2026 /PRNewswire/ -- Innodisk, a leading global AI solution provider, today announced its participation in NVIDIA GTC 2026. Alongside subsidiary Aetina, Innodisk Group is showcasing the seamless integration of NVIDIA AI architectures into scalable, deployable edge AI applications. By converging its high-performance computing platforms and the proprietary vision sensing camera modules, Innodisk is translating cutting-edge technology into field-ready industrial AI solutions across two verticals: smart healthcare and intelligent mobility.Innodisk today announced its participation in NVIDIA GTC 2026. Alongside subsidiary Aetina, Innodisk Group is showcasing the seamless integration of NVIDIA AI architectures into scalable, deployable edge AI applications.As the global AI landscape shifts from cloud-based models to edge execution, Innodisk delivers the hardware-software integration depth that industrial-scale edge AI adoption demands.","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2936621/Press_Photo__Innodisk_at_NVIDIA_GTC_2026.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2936621/Press_Photo__Innodisk_at_NVIDIA_GTC_2026.jpg?w=300"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/innodisk-at-nvidia-gtc-2026-accelerating-real-world-ai-for-healthcare-and-mobility-with-full-stack-edge-solutions-302716782.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU2471134879.HKD","LU2491049909.HKD","IE00BFSS8Q28.SGD","IE00B5949003.HKD","IE00BQXX3F31.USD","LU0094547139.USD","LU0061474705.USD","SG9999014906.USD","BK4605","LU1119994496.HKD","LU2931357623.SGD","LU2168564065.EUR","LU1066051811.HKD","IE000W1ABFV2.USD","LU2065170008.USD","NVDY","SGXZ31699556.SGD","LU0256863811.USD","BK4592","LU1496350171.SGD","LU1366333091.USD","IE00BDRTCR15.USD","LU0225283273.USD","LU0323591593.USD","LU1821325948.USD","LU2896262040.SGD","BK4581","HK0000320223.HKD","LU2602419157.SGD","LU0210533765.USD","BK4550","LU1153585028.USD","LU1127390331.HKD","LU0354030511.USD","LU1721428933.USD","IE000YTNTUN2.SGD","SG9999017495.SGD","LU0345770993.USD","ANV","LU0708995401.HKD","LU2360107168.USD","BK4585","LU0494093205.USD","LU1868837136.USD","LU2403377893.USD","LU1267930730.SGD","LU0289739343.SGD","SG9999014559.SGD","LU2326559502.SGD","LU0106261372.USD","SG9999015945.SGD","LU1861127337.USD","LU1116320901.HKD","BK4551","BK4548","LU0345768153.USD","LU2023251221.USD","2NVD.UK","LU2249611893.SGD","LU0310800379.SGD","LU2083900584.USD","LU1400636657.SGD","IE00BKPKM429.USD","LU0316494557.USD","LU1720051017.SGD","LU0820561818.USD","LU0719512351.SGD","LU2420271590.USD","LU2125909247.SGD","LU2065169927.USD","LU2054465674.USD","LU1992135472.HKD","LU1989764748.USD","LU0820561909.HKD","LU2491050154.USD","LU1852331112.SGD","SG9999014914.USD","LU2092627202.USD","LU2089283258.USD","SGXZ51526630.SGD","LU0210536198.USD","LU2361044949.HKD","IE00BZ1G4Q59.USD","LU2458330169.SGD","LU0353189680.USD","LU1670756490.USD","LU0211328371.USD","LU0077335932.USD","LU2294711713.HKD","LU2552382215.SGD","LU1868836757.USD","IE00B775SV38.USD","LU2462157665.USD","LU2430703095.HKD","IE00BYXW3230.USD","IE00B1BXHZ80.USD","LU0124676726.USD","LU1923622291.USD","LU2125909759.SGD","LU2491050071.SGD","IE0004445239.USD","IE00BKVL7J92.USD","BK4549","LU2487616109.SGD","LU1242518931.SGD","LU2272731600.USD","LU2746668461.USD","LU2265009873.SGD","LU1035775433.USD","LU2272731865.HKD","LU0708994859.HKD","SG9999004303.SGD","IE0005OL40V9.USD","LU0256863902.USD","LU1868837300.USD","LU0170899867.USD","LU2237438978.USD","LU0320765059.SGD","LU0511384066.AUD","LU0289961442.SGD","IE00B3M56506.USD","BK4588","LU2236285917.USD","NVDB","LU1244550221.USD","LU2505996681.GBP","LU1674673428.USD","LU1935043536.SGD","LU0342679015.USD","LU2360032135.SGD","LU1242518857.USD","LU0109392836.USD","HK0000306701.USD","LU1691799644.USD","LU0444971666.USD","BK4554","LU0081259029.USD","LU2168564149.EUR","LU1366192091.USD","LU1267930490.SGD","LU1699723380.USD","LU1934455277.USD","LU1429558221.USD","LU0158827948.USD","SGXZ81514606.USD","BK4528","LU0158827781.USD","LU0390134368.USD","LU1988902786.USD","LU2750360641.GBP","LU2543165471.USD","LU0965509010.AUD","LU2505996509.AUD","LU0823421416.USD","BK4023","LU2097344357.USD","LU2290526834.HKD","LU1712237335.SGD","SG9999018865.SGD","LU2168564222.USD","IE0034235303.USD","IE00B3S45H60.SGD","IE00BJTD4V19.USD","LU0683600562.USD","LU0823434583.USD","LU1934455863.HKD","LU0310799852.SGD","LU1084165304.USD","LU1244550577.SGD","LU1244550494.USD","LU1642822529.SGD","LU1935042215.USD","LU0557290698.USD","LU1923622614.USD","LU2746668974.SGD","LU0057025933.USD","LU0820562030.AUD","LU1551013425.SGD","IE0009G5SDU7.USD","IE00BJLML261.HKD","IE00BD6J9T35.USD","LU2211815571.USD","LU0979878070.USD","BK4533","LU0347712357.USD","LU2461242641.AUD","LU0053666078.USD","LU2860962120.EUR","BK4527","BK4534","LU2125154935.USD","LU2463028550.USD","3NVD.UK","IE00BMPRXR70.SGD","LU2089985449.USD","BK4009","SG9999014898.SGD","IE0009356076.USD","LU0868494617.USD","SG9999002224.SGD","LU0786609619.USD","LU1861215975.USD","LU1316542783.SGD","LU0128526141.USD","LU1400636491.USD","LU2433249047.HKD","LU0097036916.USD","LU1645745479.HKD","LU1868836591.USD","IE00BMPRXN33.USD","IE00BKDWB100.SGD","NVD","SG9999014542.SGD","IE000KEQY171.SGD","IE0004091025.USD","LU0048584097.USD","LU0069063385.USD","LU2168563687.JPY","IE00B1XK9C88.USD","SG9999014575.USD","LU0029864427.USD","LU0308772762.SGD","LU0528227936.USD","LU2065171402.SGD","LU0472753341.HKD","LU2286300806.USD","LU1718418525.SGD","LU2125909593.SGD","LU0154236417.USD","LU1983260115.SGD","LU2063271972.USD","LU0061475181.USD","LU0957791311.USD","LU1974910355.USD","LABU","LU2264538146.SGD","LU0943347566.SGD","LU2360106780.USD","LU2552382058.USD","LU2168564495.EUR","LU0444973449.USD","LU0787776722.HKD","IE00BQXX3C00.GBP","LU1400636574.HKD","LU0823421333.USD","NVDS.UK","LU0127658192.USD","LU0211327993.USD","LU0642271901.SGD","LU0234572021.USD","LU2430703251.USD","LU1145028129.USD","LU2125909916.SGD","LU0265550946.USD","IE00BQXX3D17.EUR","IE000ITXATA3.USD","LU1435385759.SGD","LU0107464264.USD","LU0203202063.USD","LU0965509101.SGD","IE00B775H168.HKD","LU0985320562.USD","SG9999018857.SGD","LU1064131342.USD","LU0070217475.USD","LU2087625088.SGD","LU2756315318.SGD","LU2322448957.HKD","BK4587","LU0882574139.USD","IE00BHPRN162.USD","LU0011850046.USD","LU0823414551.USD","LU1232071149.USD","LU0175139822.USD","LU2108987350.USD","IE0034235188.USD","SG9999015986.USD","SG9999014880.SGD","LU2458330243.SGD","SG9999015358.SGD","IE00BZ199S13.USD","LU2244417387.USD","LU0234570918.USD","LU0788109477.HKD","LU2125154778.USD","LU1803068979.SGD","LU0348723411.USD","LU2361044865.SGD","IE00BJJMRX11.SGD","LU0965509283.SGD","LU1951200564.SGD","LU1280957306.USD","BK4529","LU0289960550.SGD","LU0724617625.USD","NVDW","LU1935042488.USD","LU1868836914.USD","LU2250418816.HKD","LU0203201768.USD","LU2471134523.USD","LU1989772923.USD","SG9999014567.USD","LU0072462426.USD","SG9999000418.SGD","LU0942090050.USD","LU0689472784.USD","LU1791710582.SGD","LU1814569148.SGD","LU1323610961.USD","DIPS","LU1815333072.USD","LU2506951792.HKD","IE00BDCRKT87.USD","LU2247934214.USD","BK4614","LU1989772840.SGD","LU2452424414.USD","IE00BFSS7M15.SGD","LU1992135399.USD","SG9999002232.USD","LU2023250504.SGD","LU1037948897.HKD","IE00B7KXQ091.USD","LU0157215616.USD","LU0964807845.USD","HK0000320264.USD","LU1720051108.HKD","LU1674673691.USD","NVDX","LU1571399168.USD","LU0274383776.USD","LU2089284900.SGD","LU1791710400.SGD","LU1914381329.SGD","LU0061474960.USD","LU0029874061.USD","IE00BJTD4N35.SGD","GB00BDT5M118.USD","IE00BN29S564.USD","LU2106854487.HKD","LU1116320737.USD","LU2242650005.HKD","LU1629891620.HKD","LU0466842654.USD","NVDQ","LU1069344957.HKD","LU2023250330.USD","SG9999015341.SGD","NVDS","LU2430703178.SGD","LU2271345857.HKD","LU0476273544.USD","LU0354030438.USD","LU2092937148.SGD","LU1989764664.SGD","BK4503","LU1548497426.USD","IE0004445015.USD","LU0345770308.USD","BK4598","HK0000914660.USD","LU1633808545.USD","LU0889565833.HKD","BK4567","LU2473716301.USD","LU0353189763.USD","BK4612","LU2381873111.SGD","LU1935043023.USD","LU0267386448.USD","LU1066053197.SGD","LU2552382132.HKD","NVDA","NVDD","LU2592432038.USD","BK4137","LU0417517546.SGD","LU0640476718.USD","LU2357305700.SGD","LU2456880835.USD","LU1551013342.USD","LU2111349929.HKD","NVII","LU2077746001.SGD","LU0672654240.SGD","LU0096362180.USD","SG9999001424.SGD","HK0000914686.HKD","IE0003U64NQ7.SGD","BK4579","IE00B4JS1V06.HKD","LU2237957811.SGD","LU2191332357.HKD","IE00BMPRXQ63.HKD","IE0001KFT4U8.USD","IE00B3SWFQ91.USD","BK4141","LU0006306889.USD","LU0345768740.USD","LU0128525929.USD","LU0276348264.USD","LU2237957902.USD","LU0198837287.USD","LU2213496289.HKD","LU0266013472.USD","BK4608","LU0082616367.USD","LU0965508806.USD","LU2097344431.USD","LU2413666426.HKD","LU0080751232.USD","LU1202635105.USD","VGT","IE00B19Z8W00.USD","LU2087621335.USD","LU0215105999.USD","SGXZ23171101.USD","LU0823414478.USD","LU1839511570.USD","IE00BK4W5M84.HKD","LU0868494708.USD","LU0056508442.USD","LU2750360997.AUD","LU0187121727.USD","SG9999015978.USD","NVD2.UK","LU2242649171.HKD","AIYY","LU0345769128.USD","LU0109391861.USD","NVDG","LU2413666699.HKD","LU0345769631.USD","LU1066051225.USD","LU1951198990.SGD","SNVD.UK","IE0004086264.USD","IE00BJJMRY28.SGD","LU1804176565.USD","HK0000306685.HKD","LU0251132253.USD","IE00BWXC8680.SGD","LU0823434740.USD","LU2471134952.CNY","LU1496350502.SGD","LU2272731782.SGD","SG9999015952.SGD","IE00BK4W5L77.USD","LU1623119135.USD","LU1267930573.SGD","LU0238689110.USD","LU1923623000.USD","LU0096364046.USD","LU0210528500.USD","LU1066051498.USD","LU2322448791.USD","LU2357125470.USD","BK4543","LU0689626769.HKD","LU1261432733.SGD","LU2028103732.USD","LU0861579265.USD","LU1037948541.HKD","IE00B4YYXB79.USD","NVDU","SGXZ99366536.SGD","LU2471134796.USD","LU1934455194.USD","LU2065171311.SGD","LU0265550359.USD","LU2756315664.SGD","LU0957808578.USD","LU2361045086.USD","IE0034235295.USD","LU1935042991.SGD","IE00B19Z9505.USD","IE00B19Z8X17.USD","NVD3.UK","BK4532","LU1815336760.USD","LU1917777945.USD","XBI","NVIW.SI","LU1778281490.HKD","LU1861220033.SGD","LU2417539215.USD"],"gpt_icon":1},{"id":"2620138288","title":"Sunway Healthcare Shares Rise on Debut Despite Geopolitical Tensions","url":"https://stock-news.laohu8.com/highlight/detail?id=2620138288","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620138288?lang=en_us&edition=fundamental","pubTime":"2026-03-18 10:14","pubTimestamp":1773800040,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Sunway Healthcare soared on its trading debut, defying volatile market sentiment amid the Iran conflict.Shares of the Malaysian conglomerate's healthcare arm opened at 1.70 ringgit, equivalent to $0.43 on Wednesday and climbed as much as 26% from the IPO price of 1.45 ringgit.Sunway Healthcare raised about $736.3 million in its IPO, marking Malaysia's largest listing in nearly a decade.The company said fourth-quarter 2025 net profit rose to 112.4 million ringgit, from 78.4 million ringgit a year earlier, driven by higher patient volumes and expanded licensed bed capacity. Quarterly revenue rose 21% on year to 614.6 million ringgit.Sunway Healthcare remains cautiously optimistic about 2026, supported by resilient private healthcare demand, stabilizing new hospitals and ongoing efficiency efforts. The company added that the deferral of the Diagnosis Related Group system--which reimburses cases at a fixed rate regardless of actual treatment costs--to 2027 provides ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4137","LU0128526141.USD","XBI","BK4585","HCSG","XLV","LU0029874061.USD","BK4581","LABU"],"gpt_icon":0},{"id":"2620400954","title":"Thai Healthcare Sector Faces Headwinds From Middle East Conflict -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2620400954","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620400954?lang=en_us&edition=fundamental","pubTime":"2026-03-18 09:41","pubTimestamp":1773798060,"startTime":"0","endTime":"0","summary":"0141 GMT - Thailand's healthcare sector faces temporary headwinds from the Middle East conflict, DBS Group Research analyst Sasikarn Udomvej writes in a report. The region remains one of Thailand's key sources of medical tourists, with Bumrungrad Hospital and Praram 9 Hospital having the highest exposure to Middle Eastern patients' revenue. However the impact on the sector's 1Q earnings should be limited as the conflict coincides with the Ramadan period, which is typically a softer season for Middle Eastern medical travel. \"Once geopolitical tensions ease, we expect Middle Eastern patient demand to rebound strongly, supported by Thailand's reputation as a regional medical hub,\" DBS says. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999000343.SGD","SG9999002414.USD","LU0588545730.USD","SG9999002679.SGD","SG9999002620.SGD","SG9999014484.SGD","LU2506952170.USD","BK4588","IE00BVYPNP33.GBP","SG9999004360.SGD","LU0096374516.USD","LU0384037296.USD","SG9999003826.SGD","LU2238330802.EUR","LU2506951875.HKD","LU0029874061.USD","LU0823417737.USD","LU0762540952.USD","LU0823397103.USD","LU0061477393.USD","LU1282649067.USD","SG9999002604.SGD","LU0128526141.USD","LU0971096721.USD","LU1211504680.USD","LU0823413587.USD","LU1497733631.SGD","BK4581","SG9999014302.SGD","LU0261947096.USD","SG9999007991.SGD","LU0211331839.USD","SG9999001127.SGD","SGXZ24219693.SGD","SG9999005177.SGD","SG9999000475.SGD","LU1497733557.USD","LU0488056044.USD","LU1282649141.HKD","LU0831103253.SGD","LU0823038988.USD","SG9999000459.SGD","SG9999014492.USD","LU1634259391.SGD","LU0205439572.USD","LU0345776255.USD","LU0441854154.USD","SG9999001846.SGD","LU0441851309.USD","LU2506951958.HKD","SGXZ58947870.SGD","LU1839390173.USD","LU0823397285.USD","LU0878004406.USD","BK6516","LU0084288322.USD","LU0878005551.USD","SG9999016042.SGD","LU0886674414.USD","SG9999006266.SGD","LU2237957902.USD","LU1282649810.SGD","LU0873338254.USD","SG9999008742.SGD","SG9999001135.SGD","SG9999002562.SGD","SG9999002406.SGD","BK4137","BK6523","LU0950375773.USD","LU0955669360.SGD","LU0048597586.USD","LU0543330483.HKD","LU0672654166.SGD","LU0532188223.SGD","LU0261945553.USD","LU0128522157.USD","LU0557290698.USD","LU0675040207.SGD","LU0251143029.SGD","LU1504937902.USD","LU1522347837.USD","LU1497734951.SGD","LU0955648018.USD","LU0823039010.USD","LU0737861269.HKD","SGXZ43160589.SGD","LU0577902454.USD","LU0326948709.USD","LABU","IE0031814969.USD","LU0823417653.USD","LU1363072403.SGD","BK4585","LU0011963245.USD","LU0831093199.SGD","LU2257852520.SGD","SG9999001903.USD","LU2506952097.USD","LU0898667661.SGD","SG9999001226.SGD","LU0882747503.HKD","IE00BGHQDM52.EUR","SG9999013478.USD","LU0345775950.USD","LU1634259557.SGD","SG9999009443.AUD","LU0029875118.USD","SG9999013460.SGD","LU1956131251.USD","LU0577902538.SGD","LU0955623706.USD","LU0823413660.USD","LU0577902611.USD","XBI","LU2237957811.SGD","LU0577902371.SGD","LU0315178854.USD","SG9999003800.SGD","LU0188438112.USD","LU0251144936.SGD","LU1130305938.SGD","LU0865486749.SGD","LU0648948544.HKD","BK6112","SGXZ27511609.SGD","IE00BKZH1Z71.USD","LU0210637038.USD","SG9999013353.USD","LU0630378429.USD","LU0192582467.USD","LU0235996351.USD","LU0577902298.EUR","IE00BVYPNQ40.USD","LU1770036033.HKD","SG9999004220.SGD","SG9999011175.SGD","LU0588545490.SGD","LU0588545904.SGD","SG9999013486.USD","LU2152927971.USD","LU0048573645.USD"],"gpt_icon":1},{"id":"2620198402","title":"Icecure Medical Rides FDA, ASBRS Wins to Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2620198402","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620198402?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:16","pubTimestamp":1773792996,"startTime":"0","endTime":"0","summary":"Icecure Medical Ltd. (($ICCM)) has held its Q4 earnings call. Read on for the main highlights of the call. Icecure Medical’s latest earnings call s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-rides-fda-asbrs-wins-to-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-rides-fda-asbrs-wins-to-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4082","BK4588","BK4585","ICCM"],"gpt_icon":0},{"id":"2620401518","title":"Botanix Showcases FDA-Approved Hyperhidrosis Drug at Euroz Hartleys Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2620401518","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620401518?lang=en_us&edition=fundamental","pubTime":"2026-03-18 07:10","pubTimestamp":1773789023,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Limited ( ($AU:BOT) ) has provided an update. Botanix Pharmaceuticals has announced its participation in the annual Euroz H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/botanix-showcases-fda-approved-hyperhidrosis-drug-at-euroz-hartleys-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/botanix-showcases-fda-approved-hyperhidrosis-drug-at-euroz-hartleys-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"gpt_icon":0},{"id":"2620068814","title":"Cross Country Healthcare CIO Departs, Assumes Advisory Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2620068814","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620068814?lang=en_us&edition=fundamental","pubTime":"2026-03-18 05:31","pubTimestamp":1773783113,"startTime":"0","endTime":"0","summary":"Cross Country Healthcare ( ($CCRN) ) just unveiled an announcement. Cross Country Healthcare, Inc. reported that, effective March 10, 2026, Phil No...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cross-country-healthcare-cio-departs-assumes-advisory-role?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cross-country-healthcare-cio-departs-assumes-advisory-role?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4223","LABU","BK4196","XLV","XBI","CCRN","BK4585","BK4194","CIO","BK4581"],"gpt_icon":0},{"id":"2620140503","title":"Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620140503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620140503?lang=en_us&edition=fundamental","pubTime":"2026-03-18 05:20","pubTimestamp":1773782416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lantheus (LNTH – Research Report), Perspective Thera...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-lantheus-lnth-perspective-therapeutics-catx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-lantheus-lnth-perspective-therapeutics-catx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BLSX","BK4581","BK4585","BK4198","BK4588","CATX","LU0128526141.USD","LNTH","BK4137","LU0029874061.USD","BK4112","BLSG","BK4139","XBI"],"gpt_icon":0},{"id":"2620403064","title":"Analysts Offer Insights on Healthcare Companies: Canopy Growth (CGC) and Doximity (DOCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403064","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403064?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:40","pubTimestamp":1773780027,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Canopy Growth (CGC – Research Report) and Doximity (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-canopy-growth-cgc-and-doximity-docs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-canopy-growth-cgc-and-doximity-docs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4539","CGC","BK4137","BK4557","BK4588","XLV","BK4007","HCSG","LABU","BK4581","BK4613","LU0029874061.USD","XBI","BK4585","DOCS","BK4551","BK4167"],"gpt_icon":0},{"id":"2620403180","title":"Lantheus announces three-month extension of LNTH-2501 PDUFA date","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403180?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:22","pubTimestamp":1773778920,"startTime":"0","endTime":"0","summary":"Lantheus (LNTH) announced that the FDA has extended its review of the new drug application for LNTH-2501 by three months to June 29. The extension ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantheus-announces-three-month-extension-of-lnth-2501-pdufa-date-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantheus-announces-three-month-extension-of-lnth-2501-pdufa-date-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585","BK4198","LNTH"],"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":6,"totalSize":432,"code":"91000000","status":"200"}]}}